Literature DB >> 27569659

The quality of cortical network function recovery depends on localization and degree of axonal demyelination.

Manuela Cerina1, Venu Narayanan2, Kerstin Göbel2, Stefan Bittner3, Tobias Ruck2, Patrick Meuth2, Alexander M Herrmann2, Martin Stangel4, Viktoria Gudi5, Thomas Skripuletz5, Thiemo Daldrup6, Heinz Wiendl2, Thomas Seidenbecher6, Petra Ehling2, Christoph Kleinschnitz7, Hans-Christian Pape6, Thomas Budde6, Sven G Meuth8.   

Abstract

Myelin loss is a severe pathological hallmark common to a number of neurodegenerative diseases, including multiple sclerosis (MS). Demyelination in the central nervous system appears in the form of lesions affecting both white and gray matter structures. The functional consequences of demyelination on neuronal network and brain function are not well understood. Current therapeutic strategies for ameliorating the course of such diseases usually focus on promoting remyelination, but the effectiveness of these approaches strongly depends on the timing in relation to the disease state. In this study, we sought to characterize the time course of sensory and behavioral alterations induced by de- and remyelination to establish a rational for the use of remyelination strategies. By taking advantage of animal models of general and focal demyelination, we tested the consequences of myelin loss on the functionality of the auditory thalamocortical system: a well-studied neuronal network consisting of both white and gray matter regions. We found that general demyelination was associated with a permanent loss of the tonotopic cortical organization in vivo, and the inability to induce tone-frequency-dependent conditioned behaviors, a status persisting after remyelination. Targeted, focal lysolecithin-induced lesions in the white matter fiber tract, but not in the gray matter regions of cortex, were fully reversible at the morphological, functional and behavioral level. These findings indicate that remyelination of white and gray matter lesions have a different functional regeneration potential, with the white matter being able to regain full functionality while cortical gray matter lesions suffer from permanently altered network function. Therefore therapeutic interventions aiming for remyelination have to consider both region- and time-dependent strategies.
Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Demyelination; Gray matter lesion; Remyelination; Thalamocortical system; White matter lesion

Mesh:

Substances:

Year:  2016        PMID: 27569659     DOI: 10.1016/j.bbi.2016.08.014

Source DB:  PubMed          Journal:  Brain Behav Immun        ISSN: 0889-1591            Impact factor:   7.217


  14 in total

Review 1.  Severe Convulsions and Dysmyelination in Both Jimpy and Cx32/47 -/- Mice may Associate Astrocytic L-Channel Function with Myelination and Oligodendrocytic Connexins with Internodal Kv Channels.

Authors:  Y H Gerald Chaban; Ye Chen; Elna Hertz; Leif Hertz
Journal:  Neurochem Res       Date:  2017-02-18       Impact factor: 3.996

Review 2.  Achievements and obstacles of remyelinating therapies in multiple sclerosis.

Authors:  Martin Stangel; Tanja Kuhlmann; Paul M Matthews; Trevor J Kilpatrick
Journal:  Nat Rev Neurol       Date:  2017-11-17       Impact factor: 42.937

3.  Effects of Axonal Demyelination, Inflammatory Cytokines and Divalent Cation Chelators on Thalamic HCN Channels and Oscillatory Bursting.

Authors:  Tengiz Oniani; Laura Vinnenberg; Rahul Chaudhary; Julian A Schreiber; Kathrin Riske; Brandon Williams; Hans-Christian Pape; John A White; Anna Junker; Guiscard Seebohm; Sven G Meuth; Petra Hundehege; Thomas Budde; Mehrnoush Zobeiri
Journal:  Int J Mol Sci       Date:  2022-06-03       Impact factor: 6.208

Review 4.  What Have Failed, Interrupted, and Withdrawn Antibody Therapies in Multiple Sclerosis Taught Us?

Authors:  Julia Krämer; Heinz Wiendl
Journal:  Neurotherapeutics       Date:  2022-07-06       Impact factor: 6.088

5.  Modulation of pacemaker channel function in a model of thalamocortical hyperexcitability by demyelination and cytokines.

Authors:  Rahul Chaudhary; Stefanie Albrecht; Maia Datunashvili; Manuela Cerina; Annika Lüttjohann; Ye Han; Venu Narayanan; Dane M Chetkovich; Tobias Ruck; Tanja Kuhlmann; Hans-Christian Pape; Sven G Meuth; Mehrnoush Zobeiri; Thomas Budde
Journal:  Cereb Cortex       Date:  2022-10-08       Impact factor: 4.861

Review 6.  Failed, Interrupted, or Inconclusive Trials on Neuroprotective and Neuroregenerative Treatment Strategies in Multiple Sclerosis: Update 2015-2020.

Authors:  Niklas Huntemann; Leoni Rolfes; Marc Pawlitzki; Tobias Ruck; Steffen Pfeuffer; Heinz Wiendl; Sven G Meuth
Journal:  Drugs       Date:  2021-06-04       Impact factor: 9.546

7.  Stereological Investigation of Regional Brain Volumes after Acute and Chronic Cuprizone-Induced Demyelination.

Authors:  Tanja Hochstrasser; Sebastian Rühling; Kerstin Hecher; Kai H Fabisch; Uta Chrzanowski; Matthias Brendel; Florian Eckenweber; Christian Sacher; Christoph Schmitz; Markus Kipp
Journal:  Cells       Date:  2019-09-03       Impact factor: 6.600

Review 8.  Myelin and Modeling: Bootstrapping Cortical Microcircuits.

Authors:  Robert Turner
Journal:  Front Neural Circuits       Date:  2019-05-08       Impact factor: 3.492

Review 9.  The Cuprizone Model: Dos and Do Nots.

Authors:  Jiangshan Zhan; Teresa Mann; Sarah Joost; Newshan Behrangi; Marcus Frank; Markus Kipp
Journal:  Cells       Date:  2020-03-31       Impact factor: 6.600

10.  Protective potential of dimethyl fumarate in a mouse model of thalamocortical demyelination.

Authors:  Manuela Cerina; Venu Narayanan; Anna Delank; Patrick Meuth; Stephanie Graebenitz; Kerstin Göbel; Alexander M Herrmann; Stefanie Albrecht; Thiemo Daldrup; Thomas Seidenbecher; Ali Gorji; Tanja Kuhlmann; Heinz Wiendl; Christoph Kleinschnitz; Erwin J Speckmann; Hans-Christian Pape; Sven G Meuth; Thomas Budde
Journal:  Brain Struct Funct       Date:  2018-05-09       Impact factor: 3.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.